Quest Diagnostics
DGX
#1100
Rank
$17.54 B
Marketcap
$157.22
Share price
0.98%
Change (1 day)
14.81%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2023 (TTM): $6.76

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is $6.76. In 2022 the company made an earnings per share (EPS) of $8.06 a decrease over its 2021 EPS that were of $15.87.

EPS history for Quest Diagnostics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$6.76-16.13%
2022$8.06-49.21%
2021$15.8749.72%
2020$10.6066.67%
2019$6.3618%
2018$5.39-4.26%
2017$5.6323.19%
2016$4.57-7.11%
2015$4.9228.46%
2014$3.83-31.61%
2013$5.6060.46%
2012$3.49-16.51%
2011$4.182.45%
2010$4.084.35%
2009$3.9130.77%
2008$2.9968.93%
2007$1.77-40.6%
2006$2.989.96%
2005$2.7110.39%
2004$2.4616.35%
2003$2.1126.73%
2002$1.6690.29%
2001$0.8853.51%
2000$0.57-22900%
1999-$0.002500-101.11%
1998$0.22-216.88%
1997-$0.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$7.52 11.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.34-105.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.92-113.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.94-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.45-78.49%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands